YOUNG PHILANTHROPISTS RAISE OVER 6 MILLION TO TACKLE ALZHEIMER’S DISEASE ON THE FOOTBALL FIELD
The largest flag football non-profit organization in the country celebrates the 16th year of fundraising and awareness for Alzheimer’s Research, Care and Support.
🚪 6:00pm Doors Open
🎙 7:00pm Welcome Intros & Ceremony
🏈 7:35pm Kick-off
🎉 10:00pm After Party presented by @Community Beer Co.
🎫 Tickets are $25 donation:
https://givebutter.com/bvbdallas2023
🧠Local Beneficiaries:
https://www.bvbdallas.org/beneficiaries
The 16-year rivalry and fellowship between the Pink Team & Blue Team culminates on the football field in an epic showdown for our flagship fundraiser. The game signifies a summer of hard work to TACKLE ALZHEIMER’S – the 6th leading cause of death in the United States and the only disease among the top 10 that cannot be prevented or cured.
For the past ten weeks, more than 150 young adults have raised both awareness about the disease and funds for research among their personal networks. By game day, we hope to secure our $500,000 goal to award grants to six local organizations researching and treating Alzheimer’s Disease.
SportsRadio 1310 and 96.7FM the Ticket will be adding to the entertainment with colorful game commentators, play-by-play & streaming live on Youtube. In addition, the one and only Mavs ManiAACs will cheer on both teams along with a few more surprises throughout the night.
Every year since 2008, BvB Dallas has set ambitious goals to grow awareness, funds and hope for those facing the disease. Over 1,300 young people have contributed to the success by personally raising $1,250 or more each year. Thanks to the passion and dedication of its volunteers, the organization has persevered in the most challenging of times. Using their voices and connections for good, participants have volunteered, fundraised and educated friends, family, coworkers and the community about the need for research and scientific advancements in the diagnosis and treatment of Alzheimer’s.
DIRECTIONS
THE 2023 BVB DALLAS GRANT RECIPIENTS
BvB Dallas will continue its partnership with:
Alzheimer's Association as they seek to start the “Healthy Brain Initiative” by creating a network of Hispanic women empowered with the knowledge to influence the health outcomes of their communities. They will recruit and grow their network of volunteers in order to reach the maximum number of Hispanic women focusing on informal education to increase awareness of modifiable risk factors within the Hispanic American community. They also wish to identify new opportunities for community collaboration with organizations serving the Hispanic community, and to work alongside one another to determine dementia-related needs of the community.
Juliette Fowler Communities for two years now. This year’s funding will be an extension of their previous Dementia-Friendly Dallas Program called “I’m Still Here.” The “I’m Still Here” program philosophy will train people to increase their personal awareness and recognize signs of dementia in those around them. Individuals served could include Fowler residents and family members as well as individuals living with Alzheimer’s in the greater Dallas community. This will allow participants to offer compassionate assistance that maintains dignity for those suffering with dementia while allowing them to feel heard, feel included, and to thrive.
Senior Source via the Guardianship Program, through which the agency is appointed guardian of older adults deemed incapacitated by the Dallas County Probate Courts. All of the clients of the Guardianship Program have some sort of cognitive impairment with roughly 50% having a dementia diagnosis. Guardians make decisions pertaining to healthcare, medication, housing, and any other needed supportive services.
UT Southwestern Medical Center by funding the Clinical Neuropsychology Alzheimer’s Disease Fellowship, which provides the opportunity to rapidly develop expertise in differential diagnosis and treatment of dementia. BvB will also support UT Southwestern in their research to diagnose and treat Alzheimer’s disease by optimizing and validating techniques to deliver human tau antibodies across the blood brain barrier in patients suffering from Alzheimer’s disease.